Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21. (Q39304584)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21. |
scientific article |
Statements
1 reference
Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21. (English)
1 reference
Benhong Zhou
1 reference
Jing Wang
1 reference
Guohua Zheng
1 reference
Zhenpeng Qiu
1 reference
8 October 2016
1 reference
1 reference
97
1 reference
375-384
1 reference
Identifiers
1 reference
1 reference